1. Home
  2. KLTOW vs SNBR Comparison

KLTOW vs SNBR Comparison

Compare KLTOW & SNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • SNBR
  • Stock Information
  • Founded
  • KLTOW N/A
  • SNBR 1987
  • Country
  • KLTOW United States
  • SNBR United States
  • Employees
  • KLTOW 3
  • SNBR N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • SNBR Home Furnishings
  • Sector
  • KLTOW Health Care
  • SNBR Consumer Discretionary
  • Exchange
  • KLTOW Nasdaq
  • SNBR Nasdaq
  • Market Cap
  • KLTOW N/A
  • SNBR 154.1M
  • IPO Year
  • KLTOW 2022
  • SNBR 1998
  • Fundamental
  • Price
  • KLTOW $0.25
  • SNBR $7.44
  • Analyst Decision
  • KLTOW
  • SNBR Hold
  • Analyst Count
  • KLTOW 0
  • SNBR 2
  • Target Price
  • KLTOW N/A
  • SNBR $9.00
  • AVG Volume (30 Days)
  • KLTOW N/A
  • SNBR 502.1K
  • Earning Date
  • KLTOW N/A
  • SNBR 07-30-2025
  • Dividend Yield
  • KLTOW N/A
  • SNBR N/A
  • EPS Growth
  • KLTOW N/A
  • SNBR N/A
  • EPS
  • KLTOW N/A
  • SNBR N/A
  • Revenue
  • KLTOW N/A
  • SNBR $1,605,108,000.00
  • Revenue This Year
  • KLTOW N/A
  • SNBR N/A
  • Revenue Next Year
  • KLTOW N/A
  • SNBR $4.27
  • P/E Ratio
  • KLTOW N/A
  • SNBR N/A
  • Revenue Growth
  • KLTOW N/A
  • SNBR N/A
  • 52 Week Low
  • KLTOW N/A
  • SNBR $4.48
  • 52 Week High
  • KLTOW N/A
  • SNBR $20.75
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • SNBR 46.45
  • Support Level
  • KLTOW N/A
  • SNBR $7.44
  • Resistance Level
  • KLTOW N/A
  • SNBR $8.44
  • Average True Range (ATR)
  • KLTOW 0.00
  • SNBR 0.61
  • MACD
  • KLTOW 0.00
  • SNBR 0.11
  • Stochastic Oscillator
  • KLTOW 0.00
  • SNBR 53.61

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About SNBR Sleep Number Corporation

Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.

Share on Social Networks: